What happens if i take generess fe with water

Combined oral contraceptive COC with the synthetic estrogen ethinyl estradiol, the progestin norethindrone which has moderate androgenic and slight estrogenic activity, and ferrous fumarate tablets which provide a small amount of iron supplement during menses but no significant therapeutic value Used for routine contraception in adolescent and adult premenopausal females All COCs contain a boxed warning regarding the increased risk for thromboembolism in women who smoke.

Pills should be taken in the order directed on the blister pack. The cycle should be repeated every 28 days. Administration of most combination oral contraceptives OCs begins on the first Sunday after or on which bleeding has started. However, some clinicians suggest that administration begin on day 1 of the menstrual cycle to decrease the risk of early ovulation. If administration begins on day 1, spotting and breakthrough bleeding may be more common during the initial dosage cycle.

Patients should start the blister pack on the first Sunday after or on which bleeding has started, or alternatively, on day 1 of the menstrual cycle 1st day of menstruation. When switching from another oral contraceptive, patients should start taking this product on the same day that a new pack of the previous oral contraceptive would have been started.

Follow dose as for routine contraception dosing depends on specific product selected: in the order directed on the pack, 1 active hormone chewable tablet PO once daily for either 21 or 24 days, followed by 1 iron chewable tablet PO once daily for either 7 or 4 days. Improvement may not be noticeable for 2 to 4 months. Prolonged treatment may be needed to control condition. Treatment for 6 to 12 months may be required; OCs have limited utility when the underlying cause is not related to a hypoestrogenic or hyperandrogenic state.

Follow dose as for routine contraception dosing depends on specific product selected: in the order directed on the pack, 1 active hormone chewable tablet PO once daily for either 21 or 24 days, followed by 1 iron chewable tablet PO once daily for either 7 or 4 days ; alternatively, the active tablets can be given continuously.

Combined hormonal contraceptives can reduce endometriosis-associated dyspareunia, dysmenorrhea, and non-menstrual pelvic pain. Treatment for 6 to 9 months may be needed to induce endometrial atrophy and reduce symptoms. Hormonal contraceptives are contraindicated for use in the presence of active liver disease or markedly impaired liver function.

Specific guidelines for dosage adjustments in renal impairment are not available; it appears that no dosage adjustments are needed. Patients should be instructed to review the patient information leaflet that accompanies the norethindrone; ethinyl estradiol; ferrous fumarate prescription each time it is filled. Take at the same time each day to ensure maximum contraceptive efficacy.

To minimize nausea, administer norethindrone; ethinyl estradiol; ferrous fumarate with or after the evening meal or at bedtime. Contraceptive packs contain 28 tablets. For some packs, 21 tablets contain active hormone and 7 contain iron; for others, 24 tablets contain active hormone and only 4 contain iron. The iron tablets allow for an uninterrupted daily dosage cycle, reducing the chance of missed doses. The iron tablets are taken at the end of the cycle. Administration instructions for patients: Instruct patient on risks and warnings associated with hormonal contraceptives.

Missing norethindrone; ethinyl estradiol; ferrous fumarate pills can cause spotting or light bleeding. The length of time required for using a second method of contraception after drug initiation is slightly different for each manufacturer. In general, a second, non-hormonal form of contraception should be used until active norethindrone; ethinyl estradiol; ferrous fumarate tablets have been taken for at least 7 consecutive days.

Each manufacturer has slightly different recommendations for missed pills. Patients should be instructed to review the patient information leaflet that accompanies the prescription each time it is filled. General recommendations for missed doses: If one dose of norethindrone; ethinyl estradiol; ferrous fumarate is missed, the patient should take it as soon as she remembers and then take the next pill at the regular time as usual. It may be necessary to take 2 tablets in one day.

Some manufacturers recommend that a second method of non-hormonal contraception be used for at least 7 days after restarting the pills. If two doses in a row are missed, 2 tablets should be taken on both the day the missed doses are remembered and the following day. The regular schedule should then be continued.

A second method of non-hormonal contraception should be used for at least 7 days after restarting the pills. If 3 or more doses in a row are missed, the patient should not take the missed pills. Recommendations for restarting the pills can be found in the patient information leaflet that accompanies the prescription each time it is filled.

A second method of contraception should be used for at least 7 days after the pills are restarted. Chewable tablets: Femcon Fe chewable tablets may be chewed and swallowed or swallowed whole. If chewed, the patient should be instructed to drink a full glass 8 ounces of liquid immediately after swallowing the chewed tablet. Generess Fe chewable tablets can be chewed and swallowed without water.

Norethindrone; ethinyl estradiol; ferrous fumarate does not protect against human immunodeficiency virus HIV infection or other sexually transmitted infections STIs. Norethindrone; ethinyl estradiol; ferrous fumarate is contraindicated during pregnancy. Increased risk of a wide variety of fetal abnormalities, including modified development of sexual organs, cardiovascular anomalies, and limb defects, have been reported following the use of estrogens or synthetic progestins alone in pregnant women.

Except for effects on sexual development, the majority of recent studies do not indicate a teratogenic effect of oral contraceptives when taken inadvertently during early pregnancy. In any patient in whom pregnancy is suspected, pregnancy should be ruled out before continuing oral contraceptive use. In addition, oral contraceptive use may change folate metabolism, and women who discontinue oral contraceptives to pursue pregnancy should preferably wait 3 months for folate concentrations to normalize if possible.

Folate supplementation should be given once pregnant to reduce the incidence of neural tube defects. Recent studies have found no increased risks of birth defects among women who have inadvertently continued to take birth control pills after they unknowingly became pregnant.

Combined oral contraceptives COCs containing norethindrone; ethinyl estradiol are contraindicated in patients with hepatic disease. Because of the association with cholestasis and hepatic neoplasms, estrogens are contraindicated in the presence of hepatocellular cancer, hepatic adenoma, other liver tumors benign or malignant , or markedly impaired liver function e. Discontinue use of ethinyl norethindrone; ethinyl estradiol; ferrous fumarate if jaundice develops during COC use.

Steroid hormones may be poorly metabolized in patients with liver impairment. Acute or chronic disturbances of liver function may necessitate the discontinuation of COCs until markers of liver function return to normal and COC causation has been excluded.

Patients with hepatitis C who are being treated with ombitasvir; paritaprevir; ritonavir, with or without dasabuvir are contraindicated to receive COCs. During clinical trials with the hepatitis C combination drug regimen that contains ombitasvir; paritaprevir; ritonavir, with or without dasabuvir, ALT elevations greater than 5 times the upper limit of normal ULN , including some cases greater than 20 times the ULN, were significantly more frequent in women using ethinyl estradiol-containing medications.

Discontinue COCs before starting hepatitis C therapy with ombitasvir; paritaprevir; ritonavir, with or without dasabuvir; COCs can be restarted approximately 2 weeks after completing treatment with the hepatitis C combination drug regimen. Hepatic adenomas are associated with COC use. An estimate of the attributable risk is 3. Rupture of hepatic adenomas may cause death through intra-abdominal hemorrhage.

Studies have shown an increased risk of developing hepatocellular carcinoma in long term more than 8 years COC users. Progestin prevents pregnancy by suppressing ovulation. Estradiol is added mainly to reduce the risk of unpredictable and breakthrough bleeding , Ramanadhan explains. The major difference between various types of chewable birth control pills is simply the level of the estradiol and progestin they contain, she adds.

The original chewable birth control pill, Femcon Fe, is discontinued. However, you can still buy many other chewable birth control pills from other brands. They all have relatively similar formulas, Ramanadhan says. Chewable birth control has the same effectiveness and benefits as other combined birth control pills, Edwardson says.

Another upside to chewable birth control: You can stop taking it any time you want. With some other methods, like birth control implants, you have to visit your doctor to have the device removed. Although although combined birth control may help with some types of migraines, it should not be used by people who have migraine with aura.

Chewable birth control carries the same side effects as other combination birth control pills, Edwardson says. Most are mild and go away on their own within a few months of use. The main downside specific to chewable birth control is the limited options compared with standard birth control pills. That gives doctors fewer possibilities to switch you to another formulation if you experience side effects.

All combined hormonal birth control pills, including chewable birth control, carry a very small risk of blood clots. This can lead to deep vein thrombosis , heart attack, and stroke. Estrogen is responsible for the increased risk of clots. If you just gave birth, your doctor will also recommend waiting until 4 to 6 weeks to begin taking combined hormonal contraceptives, such as chewable birth control.

Some chewable birth control brands recommend drinking a full glass of water after you take the pill. Be sure to check the label. Newer chewable birth control brands advise against taking tablets with water to avoid diluting the hormones they contain.

If you have health insurance, you should expect to pay your insurance medication copay for chewable birth control. Reviews for chewable birth control on Drugs.

They range from an average 7 for Generess Fe to 5. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To make using hormonal contraceptives as safe and reliable as possible, you should understand how and when to use them and what effects may be expected. This medicine comes with patient instructions.

Read and follow these instructions carefully. Ask your doctor or pharmacist if you have any questions. This medicine is available in blister packs. Each blister pack contains 28 tablets with different colors that need to be taken in the same order as directed on the blister pack. When you begin using this medicine, your body will require at least 7 days to adjust before a pregnancy will be prevented.

Use a second form of contraception, such as a condom, spermicide, or diaphragm, for the first 7 days of your first cycle of pills.

You may chew and swallow the chewable tablet or swallow it whole. Drink a full glass of water 8 ounces immediately after chewing or swallowing this medicine. Do not skip or delay taking your pill by more than 24 hours. If you miss a dose, you could get pregnant. Ask your doctor for ways to help you remember to take your pills or about using another method of birth control.

You may feel sick or nauseous, especially during the first few months that you take this medicine. If your nausea is continuous and does not go away, call your doctor. If you vomit or have diarrhea within 3 to 4 hours of taking this medicine, follow the instructions in the patient leaflet or call your doctor. If you do not start your period, see your doctor for a pregnancy test.

If you have used a vaginal ring or patch, finish the 21 days of use, and wait 7 days after the ring or patch is removed before you start taking this medicine.